Cardiac risk with diphemanil methylsulfate in infants.
D017277:Drug Approval; D005602:France; D006077:Government Agencies; D006331:Heart Diseases / Q000139:chemically induced*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D010276:Parasympatholytics / Q000009:adverse effects* / Q000493:pharmacokinetics; D010880:Piperidines / Q000009:adverse effects* / Q000493:pharmacokinetics; D012306:Risk
D010276:Parasympatholytics; D010880:Piperidines